Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy

BACKGROUND: People with HIV are at for metabolic syndrome (MetS) and fatty liver disease, but the role of Antiretroviral therapy (ART) is poorly understood. MetS and fatty liver disease been associated with changes in adiponectin, soluble ST2 (sST2), chitinase 3-like 1 (Chi3L1), hyaluronic acid (HA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Offor, Obiageli, Utay, Netanya, Reynoso, David, Somasunderam, Anoma, Currier, Judith, Lake, Jordan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944924/
https://www.ncbi.nlm.nih.gov/pubmed/29746485
http://dx.doi.org/10.1371/journal.pone.0196395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944924/
https://www.ncbi.nlm.nih.gov/pubmed/29746485
http://dx.doi.org/10.1371/journal.pone.0196395

Ejemplares similares